There is no established human dosing , and clinical evidence remains limited
Eye-area copper peptide products typically use 2% or lower concentrations
Gorouhi, F
The cytoprotection concept holds innate cell (epithelial (Robert) [41,42,43], endothelial (Szabo) [44,45,46,47]) integrity, even against opposite damaging necrotizing agents (i.e., strong alcohol, boiling water, strong acid, strong base [41]) and protection/maintenance/reestablishment in the stomach to be translated to other organ therapy (cytoprotection organoprotection) [48,49] via the cytoprotection agents effect
[2] Pharmacokinetic studies demonstrate rapid systemic distribution with peak plasma levels occurring within 30-60 minutes of intramuscular injection, followed by extensive hepatic storage and enterohepatic recycling